Varian

Aspekt Solutions specializes in providing comprehensive services for the radiology and radiation oncology sectors, catering to hospitals, clinics, and healthcare systems. The company offers a wide range of diagnostic radiology services, including radiation machine inspections, quality assurance programs, and support for mammography compliance. It also focuses on nuclear medicine and imaging science, providing services such as shielding design and radiation safety program development. In the realm of radiation oncology, Aspekt Solutions develops clinical programs for external beam and brachytherapy, offers staffing solutions for medical physics and dosimetry, and assists with accreditation and quality improvement initiatives. Established in 2000 and headquartered in Lanham, Maryland, the company is staffed with qualified medical physicists, dosimetrists, and radiation safety officers, ensuring it delivers high-quality support and expertise in medical and industrial radiation applications.

Lucata Corporation is a technology company that specializes in enhancing memory utilization through its innovative hardware and software solutions. Founded in 2008 and headquartered in New York City, with additional offices in South Bend, Indiana, Lucata develops motherboards, node cards, and memory servers tailored for various applications such as graph analysis, cyber security, data warehousing, machine learning, and risk analysis. Utilizing patented migrating thread technology, Lucata enables organizations to conduct high-performance analytics on extensive databases exceeding one trillion vertices, facilitating deeper insights into complex data relationships. Its solutions are designed for sectors including financial services, healthcare, telecommunications, and government, allowing for real-time analysis and scalable memory architecture without the need for additional software layers. Lucata's architecture supports energy-efficient processing and significant performance enhancements as hardware scales, positioning the company as a key player in the evolving landscape of big data and analytics.

Bendit is a medical company specializing in the development and manufacturing of innovative catheters that utilize a unique bending technology. This technology provides enhanced steering capabilities in both micro diameter and conventional catheter wires and tubes. The company focuses on creating microcatheter devices that enable precise navigation within the body, allowing healthcare professionals to access targeted sites with minimal tools and reduced risks. Bendit's products are designed to improve the success rates of medical procedures by offering peripheral and visceral microcatheters that can be shaped and directed as needed. The company is a joint venture formed by three experienced groups in production, quality and regulation, and medical development, bringing together expertise to advance catheter technology.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

HistoSonics, Inc. is a medical technology company based in Plymouth, Minnesota, established in 2009. It specializes in developing non-invasive tumor ablation systems, notably the Edison platform. This innovative technology employs sonic beam therapy to deliver pulsed sound energy into the body, effectively liquefying and destroying targeted tissues at the sub-cellular level. By harnessing advanced imaging and proprietary sensing technology, HistoSonics provides personalized treatments with high precision and control, allowing physicians to continuously monitor the treatment's effects in real time. The platform aims to offer a safer alternative to traditional interventional and surgical methods by minimizing undesirable side effects associated with these approaches.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Zap Surgical Systems, based in San Carlos, California, specializes in developing advanced medical technologies. Founded in 2014, the company's flagship product is ZAP-X, a gyroscopic radiosurgery platform designed for precise, non-invasive treatment of brain tumors and head & neck conditions. Unlike traditional systems, ZAP-X's self-shielded design eliminates the need for radiation vaults, enabling its use in various healthcare settings previously unfeasible or cost-prohibitive.

Oncora Medical, Inc. is a digital health company based in Philadelphia, Pennsylvania, that develops an analytics platform specifically for radiation oncology. Founded in 2014, Oncora's software integrates data from various sources, including electronic medical records and treatment planning systems, to create a comprehensive database. This platform empowers radiation oncologists to use historical data and predictive analytics to make personalized treatment recommendations for cancer patients. Additionally, Oncora enables the application of machine learning algorithms to analyze patient outcomes, facilitating improved decision-making in cancer care. The company aims to enhance the effectiveness of radiation treatments by providing advanced reporting tools that unify and streamline access to critical oncology data.

Endocare, Inc. is a company based in Austin, Texas, that specializes in the development, manufacturing, and distribution of medical devices and consumables for cryoablation. The company focuses on creating systems and disposable products designed for the cryoablation of prostate and kidney tissue, as well as for the freezing of nerves in pain management. By providing these innovative solutions, Endocare enables patients to effectively treat diseased tissue, enhancing their overall healthcare options.

Cancer Treatment Services International, Inc. is a provider of comprehensive cancer treatment facilities, focusing on clinical and administrative solutions for cancer and complex diseases. Founded in 2006 and based in Pittsburgh, Pennsylvania, the company operates a network of treatment centers primarily in India and South Asia, as well as locations in Boca Raton, Florida, and Chula Vista, California. CTSI specializes in various oncology services, including radiation oncology, medical oncology, surgical oncology, and full-service diagnostics, along with support care services tailored to cancer patients. The company employs a centralized management model that incorporates standardized, evidence-based clinical pathways and operational processes to ensure consistent clinical decision-making and a patient-centric approach. Additionally, CTSI provides administrative support encompassing facility development, staff training, IT infrastructure, and quality assurance to enhance the delivery of university-level medical care.

CyberHeart, Inc. is a clinical development-stage company focused on creating a non-invasive robotic ablation treatment for cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia. Founded in 2003 and based in Mountain View, California, the company has developed the CyberHeart System, which utilizes advanced technology to dynamically detect, track, and compensate for the movement of the heart and patient during treatment. This ensures precision in the delivery of radiation. The CyberHeart System is intended for use by healthcare professionals, including radiation oncologists, medical physicists, electrophysiologists, and cardiac surgeons, to effectively treat these conditions without invasive procedures. CyberHeart operates as a subsidiary of Varian Medical Systems and has been conducting pre-clinical studies to validate the feasibility of its technology.

HistoSonics, Inc. is a medical technology company based in Plymouth, Minnesota, established in 2009. It specializes in developing non-invasive tumor ablation systems, notably the Edison platform. This innovative technology employs sonic beam therapy to deliver pulsed sound energy into the body, effectively liquefying and destroying targeted tissues at the sub-cellular level. By harnessing advanced imaging and proprietary sensing technology, HistoSonics provides personalized treatments with high precision and control, allowing physicians to continuously monitor the treatment's effects in real time. The platform aims to offer a safer alternative to traditional interventional and surgical methods by minimizing undesirable side effects associated with these approaches.

ABK Biomedical Inc. is a Halifax-based company founded in 2012 that specializes in developing embolotherapeutic products aimed at treating conditions such as uterine fibroids, hypervascular tumors, and arteriovenous malformations. The company focuses on enhancing treatment options through innovative biomaterials, particularly by transforming the interventional radiology procedure known as embolization. ABK Biomedical has developed a novel radiopaque microsphere product that serves as a bland embolic agent, emitting beta radiation to improve targeting of tumor vascularity and tissue. This innovation aims to standardize, optimize, and personalize minimally invasive therapies for better patient outcomes.

Fusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Hamilton, Canada, specializing in the development of next-generation radiopharmaceuticals as precision medicines for challenging cancers. The company leverages its Targeted Alpha Therapies platform and proprietary Fast-Clear linker technology to connect alpha particle-emitting isotopes with antibodies and other targeting molecules, enabling selective delivery of cytotoxic payloads to tumors. Its lead product candidate, FPI-1434, is currently undergoing Phase 1 clinical trials as a monotherapy for solid tumors expressing insulin-like growth factor 1 receptor. Additionally, Fusion is conducting preclinical studies to explore the combination of FPI-1434 with approved checkpoint inhibitors and DNA damage response inhibitors to enhance anti-tumor activity. The company is also advancing FPI-1966, aimed at treating head and neck and bladder cancers that express fibroblast growth factor receptor. Founded in 2014, Fusion Pharmaceuticals aims to innovate within the field of radiopharmaceuticals, transforming internalizing antibodies into effective cytotoxic drugs for improved cancer treatment outcomes.

Noona Healthcare Oy, established in 2014 and headquartered in Helsinki, Finland, specializes in developing a Web-based mobile service called Noona. This platform enables breast cancer patients to directly report treatment-related symptoms to their clinics via mobile phones, tablets, and computers, fostering real-time, holistic patient monitoring. Additionally, Noona's platform facilitates scientific research by generating digital data that combines patient diagnosis, treatment, and genetic information, aiding in the development of new cancer therapies. As of 2018, Noona Healthcare operates as a subsidiary of Varian Medical Systems, Inc.

HumediQ Global, established in 2010 and headquartered in Grünwald, Germany, specializes in the development, manufacturing, and sales of medical-technical systems. With a team of 10, the company focuses on quality assurance systems in radiotherapy, creating innovative hardware and software solutions. Their flagship product is an automated patient identification, positioning, and motion management system for radiation therapy, featuring a palm reader for patient identification, automatic synchronization with oncology information systems, and surface-guided radiation therapy (SGRT) cameras for real-time patient positioning and motion monitoring. This enables healthcare professionals to enhance treatment quality and minimize errors. HumediQ Global works closely with hospitals and research institutions to integrate scientific research results into clinical practice. As of 2018, the company operates as a subsidiary of Varian Medical Systems, Inc.

Gamma Basics is a software development company that specializes in solutions for the radiation oncology, nuclear medicine, and diagnostic imaging sectors. The company is best known for its flagship product, grayCAD, which is the only medical radiation safety computer-aided design software available in the market. grayCAD enables healthcare facilities to design and analyze radiation shielding in accordance with architectural drawings and local regulations, thereby assisting hospitals in assessing their compliance with radiation safety standards when upgrading equipment. Through its innovative software applications, Gamma Basics addresses critical safety needs within the medical community, enhancing protection for patients and staff alike.

Cooperative CL Enterprises, a distributor of radiotherapy equipment in Taiwan. COOP currently employs 45 people, and has represented Varian in Taiwan for more than 40 years.

Evinance Innovation is a Montreal-based company specializing in clinical decision support software aimed at enhancing patient-centric healthcare. The company has developed a patented Decision Support Platform that facilitates shared decision-making between healthcare providers and patients by integrating evidence-based guidelines into the clinical workflow. This platform employs virtual patient paths to improve communication and collaboration, ensuring that healthcare decisions are informed and tailored to individual patient needs. Evinance's technology works seamlessly with any electronic health record system, accommodates various medical specialties, and is adaptable to multiple languages, thus promoting a more integrated approach to healthcare delivery.

Mobius Medical Systems, based in Houston, Texas, specializes in the development of radiation oncology quality assurance software, which is designed to improve treatment outcomes in cancer care. Founded in 2010, the company has established itself as a leader in this field, with its software utilized at over 1,000 sites worldwide to ensure high-quality patient care. The flagship product, Mobius3D, is a 3D dose verification and treatment delivery QA system specifically for Intensity-Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Therapy (VMAT). It performs comprehensive 3D dose verifications of patient treatment plans while supporting verification checks throughout the clinical process, providing medical physicists with modular staged testing to enhance confidence in treatment delivery. Additionally, the company offers DoseLab, a user-friendly software tool for quality assurance of medical linear accelerators, further solidifying Mobius Medical Systems' commitment to enhancing safety and efficacy in radiation oncology. As of early 2018, Mobius operates as a subsidiary of Varian Medical Systems, Inc.

Arterys Inc. is a pioneering company in the field of medical imaging analytics, focused on transforming healthcare through advanced radiology solutions. Established in 2007 and headquartered in San Francisco, California, with additional offices in Calgary, Canada, and Paris, France, Arterys offers a web-based, AI-powered platform that is FDA-cleared and designed to enhance patient care. Its suite of products includes Cardio AI for cardiac magnetic resonance image analysis, Lung AI for lung imaging, Liver AI for liver imaging, and Chest/MSK AI, which automates the detection of various conditions such as fractures and pulmonary nodules. Additionally, the Arterys PHI Service allows physicians to access patient data remotely. The platform's innovative technology enables radiologists to visualize and quantify blood flow in the human body, facilitating improved diagnostic capabilities and clinical decision-making.

Fusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company based in Hamilton, Canada, specializing in the development of next-generation radiopharmaceuticals as precision medicines for challenging cancers. The company leverages its Targeted Alpha Therapies platform and proprietary Fast-Clear linker technology to connect alpha particle-emitting isotopes with antibodies and other targeting molecules, enabling selective delivery of cytotoxic payloads to tumors. Its lead product candidate, FPI-1434, is currently undergoing Phase 1 clinical trials as a monotherapy for solid tumors expressing insulin-like growth factor 1 receptor. Additionally, Fusion is conducting preclinical studies to explore the combination of FPI-1434 with approved checkpoint inhibitors and DNA damage response inhibitors to enhance anti-tumor activity. The company is also advancing FPI-1966, aimed at treating head and neck and bladder cancers that express fibroblast growth factor receptor. Founded in 2014, Fusion Pharmaceuticals aims to innovate within the field of radiopharmaceuticals, transforming internalizing antibodies into effective cytotoxic drugs for improved cancer treatment outcomes.

Varex's components are used in medical imaging as well as in industrial and security imaging applications. Global OEM manufacturers.

Candela's radiotherapy business is a distributor of radiotherapy equipment in Poland.

TrueBeam systems will enable us to make advanced cancer care accessible to even more patients.

Claymount is a designer and manufacturer wants to add value to your X-ray system through Technology Excellence and Cost Leadership.

MeVis Medical Solutions AG, founded in 1992 and based in Bremen, Germany, specializes in developing and marketing software for analyzing and evaluating medical image data. The company primarily serves equipment manufacturers of medical devices and providers of medical IT platforms in the United States and Europe. MeVis operates through two main segments: Digital Mammography and Other Diagnostics. The Digital Mammography segment focuses on software products that enhance breast diagnostic imaging and intervention, including applications for ultrasound and magnetic resonance imaging. The Other Diagnostics segment offers digital radiology solutions for various diseases such as lung, prostate, and intestinal disorders, along with general analysis of radiological images. Additionally, MeVis provides interactive online training to improve the diagnostic capabilities of its clinical customers. The company is recognized as a leading independent developer in the medical software field and operates as a subsidiary of Varex Imaging Deutschland AG.

Transpire, Inc. develops simulation software products that predict the macroscopic behavior of radiation for various industries.

Velocity Medical Solutions is a developer of advanced imaging software aimed at enhancing cancer treatment. The company specializes in oncology Picture Archiving and Communication Systems (PACS) that have broad applications across research, clinical practice, and drug discovery. Its key offerings include VelocityAI, an imaging informatics tool that facilitates the swift creation of radiation therapy plans and evaluates therapy effectiveness; VelocityGRID, a vendor-neutral platform that consolidates image, structure, plan, and dose data to form a comprehensive patient dataset; and VelocityConnect, a collaborative platform designed to improve communication with referring physicians. Through these solutions, Velocity Medical Solutions seeks to optimize radiation therapy planning and contribute to the development of new cancer therapies.

Applied Computational Technologies is a software development company specializing in applications for the life sciences sector, particularly in radiation treatment planning for cancer therapy. The company has developed innovative software products, including ProACTive, a dose calculation engine designed to facilitate treatment planning for adaptive radiotherapy. With a significant number of cancer diagnoses in the United States, where a large percentage of patients undergo radiation therapy, Applied Computational Technologies aims to enhance the precision and effectiveness of cancer treatments through its advanced technological solutions.

Infimed, Inc. provides software and hardware for medical imaging. The company specializes in digital medical imaging systems for fluoroscopy, angiography, cardiology, general radiography, and digital radiography. It offers i5 DR, a digital radiography imaging system for dealers and OEM; and i5 RF/DSA, a digital fluoroscopy imaging system to acquire, review and alter, store, export, and print images. The company also provides iCynergy to acquire RF camera and static wireless DR panel images; PlatinumOne that improves the productivity of fluoroscopy, angiography, urology, and cardiology procedures; and i5 Nexus-DRF that includes InfiVision, an automatic image enhancement software. It serves customers in Asia, Europe, North America, the Russian Federation, China, and South America. The company was founded in 1983 and is based in Liverpool, New York. As of April 3, 2012, Infimed, Inc. operates as a subsidiary of Varian Medical Systems Inc

Calypso Medical Technologies is a Seattle-based medical device company that specializes in real-time localization technology for tumor tracking. Its proprietary system employs miniaturized implanted devices, known as Beacon electromagnetic transponders, to continuously and accurately monitor the location of tumors. This innovative approach aims to enhance the precision and management of radiation therapy delivery, particularly for body-wide cancers commonly treated with this method. The company's products have received FDA 510(k) clearance for use in the prostate and post-operative prostatic bed. Calypso Medical has established strategic partnerships with major industry players, including Varian Medical Systems, Siemens Medical Systems, Elekta Corporation, and Philips Medical.

SpaceOAR is a privately held medical device company developing in-situ formed, space-filling hydrogels specifically for radiation oncology and cancer surgery indications. Its hydrogel is clinically proven to minimize side effects and protect the quality of life for prostate cancer patients undergoing radiation therapy that enables healthcare providers to minimize urinary, sexual, and bowel side effects of the patients. It was founded in 2007 and is headquartered in Bedford, Massachusetts.

IKOEngelo, a medical knowledge-based system that enables the practice to operate IMRT at various levels of quality and efficiency.

Pan-Pacific Enterprises, Inc. distributes medical diagnostic equipment in China, the United states, and internationally.

Bio-Imaging Research. designs and manufactures medical and industrial imaging systems for medical‚ industrial‚ and security applications.

ACCEL Instruments GmbH, a privately held supplier of scientific research instruments and proton therapy systems for cancer treatment.

Sigma Micro Informatique Conseil, a privately-held company that is the leading supplier of information management software for radiation oncology and medical oncology in cancer clinics and hospitals in France and other European nations. Varian paid approximately $13 million in cash to acquire the company, which is based in Toulouse, France.

OpTx Corporation develops solutions for oncology practices in the areas of patient management.

Zmed, Inc. supplies stereotactic radiosurgery and precision radiotherapy products.Developer of radiation oncology software intended to improve clinical performance in medical imaging intensive applications. The company supplies radiation oncology software and accessories for ultrasound-based, image-guided radiotherapy (IGRT), stereotactic radiation treatments and image management.

MRW GmbH, a prominent reloader and distributor of medical X-ray tubes in Germany.

HDR brachytherapy a minimally invasive procedure for eradicating cancerous tumors with radiation.

Argus Software, Inc designs and develops quality control information management software.

IMPAC Medical Systems offers comprehensive IT solutions for cancer care facilities worldwide. Their product suite encompasses device connectivity systems, medical imaging products, practice management software, anatomic pathology system, data aggregation tools, and electronic data interchange platforms. These integrated solutions facilitate efficient management of cancer care complexities, from detection to treatment follow-up. Additionally, IMPAC provides implementation services, training, support, upgrades, transition management, network services, and remote hosting to ensure smooth operation and continuous improvement in cancer care delivery.

Multimedia Medical Systems, Inc. of Charlottesville, Va., to expand its product line for addressing the treatment of prostate cancer.

dpiX is a a-Si technology firm that focuses on research, engineering, development, and manufacturing.